Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Pertussis Vaccine Market?

In recent times, there has been a steady increase in the size of the pertussis vaccine market. It is anticipated that the market will expand from a value of $5.5 billion in 2024 to around $5.72 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.1%. This growth during the historic period is likely due to factors such as the prevalence of the disease, implementation of immunization programs, pediatric vaccinations, and regulatory approvals.

What Growth Rate Is Forecasted for the Pertussis Vaccine Market by 2029?

The market for the pertussis vaccine is predicted to experience consistent expansion in the coming years, reaching a size of $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 3.7%. This predicted growth during the forecast period can be credited to factors such as booster vaccination, immunization for expecting mothers, healthcare worker immunization, and international health campaigns. Key trends expected to characterize the forecast period comprise personalized vaccination timetables, combined vaccines, initiatives promoting equal access to vaccines, and the use of digital health strategies in immunization processes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Key Companies Are Shaping the Future of the Pertussis Vaccine Market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Which Factors Are Driving Demand in the Pertussis Vaccine Industry?

The uptick in childbirth rates is propelling the expansion of the pertussis vaccine market. Childbirth signifies the process of delivering a baby, concluding the pregnancy phase during which the fetus grows in the mother’s womb, signifying the dawn of a new existence outside the womb. The pertussis vaccine is vital for children as it offers protection against whooping cough and other grave and potentially fatal diseases. A report issued in January 2023 by the Centers for Disease Control and Prevention, a public health organization based in the US, showed that the United States had a 1% rise in registered births from the previous year, accumulating to 3,664,292. Hence, the escalating rate of childbirths is propelling the pertussis vaccine market’s growth.

Pertussis Vaccine Market Driver: Growth in Geriatric Population Fuels Pertussis Vaccine Market Expansion

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

How Is the Pertussis Vaccine Market Segmented by Several Divisions?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

What are the Emerging Market Trends Driving the Growth of the Pertussis Vaccine Industry?

Leading firms in the pertussis vaccine market are innovating and gaining approvals for new drugs to maintain their competitiveness. For example, in October 2022, GSK plc., a pharmaceutical and biotechnology company based in the UK, revealed that the U.S. Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine is a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). It is administered during pregnancy to protect newborns from pertussis, also known as whooping cough. BOOSTRIX is administered through a single injection to the upper arm muscle and has been proven to be safe and effective for expectant mothers and their infants. Importantly, it provides robust protection against pertussis, even in severe instances of the disease.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Regions Are Driving Growth in the Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

This Report Delivers Insight On:

1. How big is the pertussis vaccine market, and how is it changing globally?

2. Who are the major companies in the pertussis vaccine market, and how are they performing?

3. What are the key opportunities and risks in the pertussis vaccine market right now?

4. Which products or customer segments are growing the most in the pertussis vaccine market?

5. What factors are helping or slowing down the growth of the pertussis vaccine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model